Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing.
Saved in:
| Title: | Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing. |
|---|---|
| Authors: | Pal T; Department of Medicine, Vanderbilt-Ingram Cancer Center, University Medical Center, Vanderbilt University, Nashville, TN, USA. tuya.pal@vumc.org., Mundt E; Myriad Genetics, Salt Lake City, UT, USA., Richardson ME; Ambry Genetics, Aliso Viejo, CA, USA., Chao E; Ambry Genetics, Aliso Viejo, CA, USA., Pesaran T; Ambry Genetics, Aliso Viejo, CA, USA., Slavin TP; Myriad Genetics, Salt Lake City, UT, USA., Couch FJ; Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, 55905, USA., Monteiro ANA; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA. alvaro.monteiro@moffitt.org. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2024 Nov 02; Vol. 8 (1), pp. 247. Date of Electronic Publication: 2024 Nov 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-024-00741-4 |
